Plasma Cholecystokinin Response to Oral Fat in Patients with Billroth I and Billroth II Gastrectomy
- 1 March 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 199 (3) , 276-280
- https://doi.org/10.1097/00000658-198403000-00005
Abstract
The present study was undertaken to determine whether bypassing the duodenum in patients with Billroth II gastrectomy affects plasma cholecystokinin (CCK) release in response to ingestion of fat. Plasma CCK concentrations were measured by radioimmunoassay using two antibodies; antibody 1703 binds to all carboxl-terminal CCK-peptides containing at least 14 amino acid residues, while antibody T204 is specific for the sulphated tyrosine region of CCK. There were no significant differences among fasting plasma CCK concentrations in seven patients with Billroth II gastrectomy (1.3 ± 0.4 fmol/ml, antibody 1703; 2.6 ± 0.4 fmol/ml, antibody T204), six patients with Billroth I gastrectomy (0.6 ± 0.3 fmol/ml, antibody 1703; 2.9 ± 0.5 fmol/ml, antibody T204), and nine normal subjects (0.7 ± 0.1 fmol/ml, antibody 1703; 1.9 ± 0.3 fmol/ml, antibody T204). Ingestion of 250 ml 20% Intralipid induced similar increases in plasma CCK in patients with Billroth II gastrectomy (11.2 ± 2.0 fmol/ml, antibody 1703; 10.1 ± 2.4 fmol/ml, antibody T204) as in patients with Billroth I gastrectomy (11.8 ± 2.0 fmol/ml, antibody 1703; 8.4 ± 1.1 fmol/ml, antibody T204). However, the increments in plasma CCK in patients with gastrectomy (11.5 ± 1.4 fmol/ml, antibody 1703; 9.3 ± 1.4 fmol/ml, antibody T204) were significantly (p < 0.01) greater than those in normal subjects (4.7 ± 0.8 fmol/ml, antibody 1703; 4.1 ± 0.7 fmol/ml). Similarly, the integrated plasma CCK secretion in patients with Billroth II gastrectomy (510 ± 58 fmol/ml.120 min, antibody 1703; 458 ± 69 fmol/ml.120 min, antibody T204) and in patients with Billroth I gastrectomy (457 ± 143 fmol/ml.120 min, antibody 1703; 365 ± 61 fmol/ml.120 min, antibody T204) were significantly (p < 0.05) greater than in normal subjects (230 ± 49 fmol/ml.120 min, antibody 1703; 162 ± 24 fmol/ml.120 min, antibody T204). It is concluded that the plasma CCK response to oral fat is significantly greater in patients with partial gastrectomy than in normal subjects, and that patients with Billroth I and Billroth II gastrectomy have similar increases in plasma CCK after ingestion of fat.This publication has 19 references indexed in Scilit:
- Molecular forms of cholecystokinin in human plasma during infusion of bombesinLife Sciences, 1983
- Radioimmunoassay of cholecystokinin in human tissue and plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- Identification and measurement of molecular variants of cholecystokinin in duodenal mucosa and plasma. Diminished concentrations in patients with celiac disease.Journal of Clinical Investigation, 1982
- Distribution of the gut hormones in the primate intestinal tract.Gut, 1979
- SENSITIVE BIOASSAY OF CHOLECYSTOKININ IN HUMAN SERUMThe Lancet, 1973
- Pancreozymin bioassay in man based on pancreatic enzyme secretion: potency of specific amino acids and other digestive productsJournal of Clinical Investigation, 1970
- Gall-stones and gastric surgery. A reviewBritish Journal of Surgery, 1968
- Cholecystitis and cholelithiasis as a sequel to gastric surgeryThe American Journal of Surgery, 1965
- CHOLECYSTITIS FOLLOWING GASTRIC SURGERYThe Lancet, 1964
- Gall-bladder Complications following Resection of StomachBMJ, 1947